Free Trial

Myomo (MYO) Projected to Post Earnings on Wednesday

Myomo logo with Medical background

Myomo (NYSEAMERICAN:MYO - Get Free Report) is expected to be announcing its Q1 2025 earnings results after the market closes on Wednesday, May 7th. Analysts expect the company to announce earnings of ($0.08) per share and revenue of $9.22 million for the quarter.

Myomo Price Performance

Shares of NYSEAMERICAN:MYO traded down $0.02 during midday trading on Tuesday, reaching $4.72. The company had a trading volume of 170,650 shares, compared to its average volume of 415,662. The stock has a market cap of $142.63 million, a PE ratio of -20.50 and a beta of 1.68. The company's fifty day simple moving average is $4.85. Myomo has a one year low of $2.76 and a one year high of $7.17.

Analyst Ratings Changes

A number of research analysts have recently issued reports on MYO shares. Alliance Global Partners restated a "buy" rating on shares of Myomo in a research report on Tuesday, March 11th. Craig Hallum upped their price objective on shares of Myomo from $9.00 to $11.00 and gave the stock a "buy" rating in a report on Tuesday, March 11th. HC Wainwright lifted their price target on Myomo from $7.50 to $9.50 and gave the company a "buy" rating in a research report on Wednesday, March 12th. Finally, Ascendiant Capital Markets lifted their price target on shares of Myomo from $9.00 to $11.00 and gave the stock a "buy" rating in a research report on Monday, March 17th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $9.75.

View Our Latest Research Report on Myomo

Insiders Place Their Bets

In related news, Director Thomas F. Kirk purchased 7,400 shares of the firm's stock in a transaction dated Thursday, March 13th. The stock was bought at an average price of $5.00 per share, for a total transaction of $37,000.00. Following the purchase, the director now owns 255,933 shares in the company, valued at $1,279,665. The trade was a 2.98 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Micah Mitchell sold 48,000 shares of the stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $5.16, for a total value of $247,680.00. Following the transaction, the insider now owns 140,572 shares in the company, valued at approximately $725,351.52. This trade represents a 25.45 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.54% of the company's stock.

About Myomo

(Get Free Report)

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.

Featured Stories

Earnings History for Myomo (NYSEAMERICAN:MYO)

Should You Invest $1,000 in Myomo Right Now?

Before you consider Myomo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Myomo wasn't on the list.

While Myomo currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines